Amyloid β Peptides and Presenilins in the Pathogenesis of Alzheimer's Disease (Symposium VIIHistochemistry for Neuroscience Research)
スポンサーリンク
概要
- 論文の詳細を見る
Amyloid β peptides, especially those ending at the 42nd residue (Aβ42), is the initially and predominantly deposited Aβ species in the brains of patients with Alzheimer's disease and Down's syndrome. The pathogenetic significance of overproduction and/or deposition of Aβ42 is highlighted because mutations in multiple different genes responsible for early-onset familial Alzheimer's disease, i.e. those in βAPP, presenilin 1 and 2 genes,led to an increase in the secretion and depositidn of Aβ42.
著者
-
Iwatsubo Takeshi
Department Of Neuropathology And Neuroscience Graduate School Of Pharmaceutical Sciences University
-
Iwatsubo Takeshi
東京大学 薬学系研究科臨床薬学教室
関連論文
- Immunoreactivity of Phage Library-derived Human Single-Chain Antibodies to Amyloid Beta Conformers In Vitro
- Pathological biochemistry of α-synucleinopathy
- Discussions on phosphorylated tau and other biochemical markers
- Discussions on laminin as possible biomarkers for neurodegenerative dementia
- Discussions on role of neprilysin and degradating system
- Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model
- Amyloid β Peptides and Presenilins in the Pathogenesis of Alzheimer's Disease (Symposium VIIHistochemistry for Neuroscience Research)
- Pax6-5a Promotes Neuronal Differentiation of Murine Embryonic Stem Cells
- Molecular Pathogenesis of Alzheimer's Disease
- Tauopathy : An overview
- Effects of Image Distortion Correction on Voxel-based Morphometry
- Dementia of Old People: Recent Advances in Epidemiology, Diagnosis, Treatment, Care, and Research 2. Molecular Pathogenesis of Alzheimer's Disease